Piqur Therapeutics Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Out of Business

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Liquidation

Piqur Therapeutics General Information

Description

Developer of targeted oncology and dermatology medicines intended for the treatment of cancer and genetic diseases. The company's medicines aim at extending and improving the lives of cancer patients, enabling cancer patients to recover and have a healthy life.

Contact Information

Website
www.piqur.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Arnold Böcklin-Strasse 25
  • C/o Wirtschafts-Treuhand AG
  • 4051 Basel
  • Switzerland
+41 061
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Corporate Office
  • Arnold Böcklin-Strasse 25
  • C/o Wirtschafts-Treuhand AG
  • 4051 Basel
  • Switzerland
+41 061

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Piqur Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Bankruptcy: Liquidation 29-Sep-2021 Completed Bankruptcy: Liquidation
11. Later Stage VC 15-Apr-2019 Completed Generating Revenue
10. Later Stage VC (Series B) 15-Nov-2017 Cancelled Generating Revenue
9. Later Stage VC (Series A3) 01-Sep-2017 Completed Generating Revenue
8. Early Stage VC (Series A2) 16-Jul-2015 Completed Generating Revenue
7. Early Stage VC (Series A) 08-Apr-2014 Completed Generating Revenue
6. Seed Round 05-Sep-2013 Completed Generating Revenue
5. Grant Completed Generating Revenue
4. Seed Round 01-Oct-2012 $3.1M $3.1M Completed Generating Revenue
3. Seed Round Completed Startup
To view Piqur Therapeutics’s complete valuation and funding history, request access »

Piqur Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary shares
Series A3
Series A2
Series A
Ordinary shares
Ordinary shares
Ordinary shares
Ordinary shares 43,308 $0.100210 $1.54 $1.54 1x $1.54 0.74%
Ordinary shares 50,000 $0.100210 $0.2 $0.2 1x $0.2 0.85%
To view Piqur Therapeutics’s complete cap table history, request access »

Piqur Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of targeted oncology and dermatology medicines intended for the treatment of cancer and genetic diseases. The
Drug Discovery
Basel, Switzerland
9 As of 2021

South San Francisco, CA
 

Cleveland, OH
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Piqur Therapeutics Competitors (79)

One of Piqur Therapeutics’s 79 competitors is Genentech, a Formerly VC-backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genentech Formerly VC-backed South San Francisco, CA
Abeona Therapeutics Corporation Cleveland, OH
IFM Therapeutics Venture Capital-Backed Boston, MA
Auron Therapeutics Venture Capital-Backed Newton, MA
Argos Therapeutics Venture Capital-Backed Durham, NC
You’re viewing 5 of 79 competitors. Get the full list »

Piqur Therapeutics Patents

Piqur Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210299133-A1 Treatment of squamous cell carcinoma Inactive 07-Aug-2018
US-20250367210-A1 Treatment of squamous cell carcinoma Pending 07-Aug-2018
WO-2020030708-A1 Treatment of squamous cell carcinoma Inactive 07-Aug-2018
WO-2019101853-A1 Treatment of skin disorders Inactive 23-Nov-2017
WO-2017198346-A1 Treatment of neurological disorders Inactive 18-May-2016 A61K31/5377
To view Piqur Therapeutics’s complete patent history, request access »

Piqur Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Piqur Therapeutics FAQs

  • When was Piqur Therapeutics founded?

    Piqur Therapeutics was founded in 2011.

  • Where is Piqur Therapeutics headquartered?

    Piqur Therapeutics is headquartered in Basel, Switzerland.

  • What is the size of Piqur Therapeutics?

    Piqur Therapeutics has 9 total employees.

  • What industry is Piqur Therapeutics in?

    Piqur Therapeutics’s primary industry is Drug Discovery.

  • Is Piqur Therapeutics a private or public company?

    Piqur Therapeutics is a Private company.

  • What is Piqur Therapeutics’s current revenue?

    The current revenue for Piqur Therapeutics is .

  • How much funding has Piqur Therapeutics raised over time?

    Piqur Therapeutics has raised $97.7M.

  • Who are Piqur Therapeutics’s competitors?

    Genentech, Abeona Therapeutics, IFM Therapeutics, Auron Therapeutics, and Argos Therapeutics are some of the 79 competitors of Piqur Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process